These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71. Inhibition, by drugs, of galactosamine induced hepatitis in the rat. Pickering RW; Lynn James GW; Parker FL Arzneimittelforschung; 1975 Oct; 25(10):1591-2. PubMed ID: 1243044 [TBL] [Abstract][Full Text] [Related]
72. Proceedings: Studies of the effects of intravascular coagulation on the rabbit kidney. Wardle EN Clin Sci Mol Med; 1974 Jan; 46(1):5P. PubMed ID: 4811874 [No Abstract] [Full Text] [Related]
73. [Behavior of 125-I-fibrinogen and 131-I-albumin in experimental galactosamine hepatitis]. von Mahn I; Merkel H; Sattler EL; Müller-Berghaus G Verh Dtsch Ges Inn Med; 1974; 80():437-9. PubMed ID: 4454578 [No Abstract] [Full Text] [Related]
74. [The lungs and disseminated intravascular coagulation]. Hasegawa H Rinsho Byori; 1985 Jun; Spec No 63():105-11. PubMed ID: 3900480 [No Abstract] [Full Text] [Related]
75. [Consumption coagulopathy with fibrin rich microcoagula in experimental rabbit hepatitis]. Reuter C; Müller-Berghaus G Verh Dtsch Ges Inn Med; 1973; 79():1340-2. PubMed ID: 4790175 [No Abstract] [Full Text] [Related]
76. Experimental galactosamine-induced hepatitis. Effect of anticoagulant and antifibrinolytic agents on microclot formation. Müller-Berghaus G; Reuter C; Bleyl U Am J Pathol; 1976 Feb; 82(2):393-406. PubMed ID: 1251892 [TBL] [Abstract][Full Text] [Related]
77. Behaviour of 125I-fibrinogen and 131I-albumin in experimental galactosamine-induced hepatitis. Mahn I; Merkel H; Sattler EL; Müller-Berghaus G Gut; 1977 Jul; 18(7):547-55. PubMed ID: 873336 [TBL] [Abstract][Full Text] [Related]